national pharmaceutical association limited
national pharmaceutical association limited Company Information
Company Number
04141489
Next Accounts
Sep 2025
Industry
Activities of business and employers membership organisations
Shareholders
national pharmacy association
Group Structure
View All
Contact
Registered Address
mallinson house, 38-42 st peters street, st albans, herts, AL1 3NP
Website
http://npa.co.uknational pharmaceutical association limited Estimated Valuation
Pomanda estimates the enterprise value of NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED at £2 based on a Turnover of £4 and 0.57x industry multiple (adjusted for size and gross margin).
national pharmaceutical association limited Estimated Valuation
Pomanda estimates the enterprise value of NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED at £0 based on an EBITDA of £0 and a 2.81x industry multiple (adjusted for size and gross margin).
national pharmaceutical association limited Estimated Valuation
Pomanda estimates the enterprise value of NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED at £2 based on Net Assets of £1 and 2.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
National Pharmaceutical Association Limited Overview
National Pharmaceutical Association Limited is a live company located in st albans, AL1 3NP with a Companies House number of 04141489. It operates in the activities of business and employers membership organizations sector, SIC Code 94110. Founded in January 2001, it's largest shareholder is national pharmacy association with a 100% stake. National Pharmaceutical Association Limited is a mature, micro sized company, Pomanda has estimated its turnover at £4.4 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
National Pharmaceutical Association Limited Health Check
Pomanda's financial health check has awarded National Pharmaceutical Association Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 5 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
5 Weak
Size
annual sales of £4.4, make it smaller than the average company (£1.5m)
- National Pharmaceutical Association Limited
£1.5m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- National Pharmaceutical Association Limited
- - Industry AVG
Production
with a gross margin of 40.7%, this company has a higher cost of product (74.7%)
- National Pharmaceutical Association Limited
74.7% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- National Pharmaceutical Association Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (15)
- National Pharmaceutical Association Limited
15 - Industry AVG
Pay Structure
on an average salary of £52.9k, the company has an equivalent pay structure (£52.9k)
- National Pharmaceutical Association Limited
£52.9k - Industry AVG
Efficiency
resulting in sales per employee of £4.4, this is less efficient (£116.4k)
- National Pharmaceutical Association Limited
£116.4k - Industry AVG
Debtor Days
it gets paid by customers after 82 days, this is later than average (39 days)
- National Pharmaceutical Association Limited
39 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- National Pharmaceutical Association Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- National Pharmaceutical Association Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - National Pharmaceutical Association Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - National Pharmaceutical Association Limited
- - Industry AVG
NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED financials
National Pharmaceutical Association Limited's latest turnover from December 2023 is estimated at £4 and the company has net assets of £1. According to their latest financial statements, we estimate that National Pharmaceutical Association Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | ||||||||||||
| Other Income Or Grants | 0 | 0 | 0 | ||||||||||||
| Cost Of Sales | 0 | 0 | 0 | ||||||||||||
| Gross Profit | 0 | 0 | 0 | ||||||||||||
| Admin Expenses | 0 | 0 | 0 | ||||||||||||
| Operating Profit | 0 | 0 | 0 | ||||||||||||
| Interest Payable | 0 | 0 | 0 | ||||||||||||
| Interest Receivable | 0 | 0 | 0 | ||||||||||||
| Pre-Tax Profit | 0 | 0 | 0 | ||||||||||||
| Tax | 0 | 0 | 0 | ||||||||||||
| Profit After Tax | 0 | 0 | 0 | ||||||||||||
| Dividends Paid | 0 | 0 | 0 | ||||||||||||
| Retained Profit | 0 | 0 | 0 | ||||||||||||
| Employee Costs | 0 | 0 | 0 | ||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* | 0 | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total shareholders funds | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 0 | 0 | 0 | ||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Tax | 0 | 0 | 0 | ||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 0 | 0 | -1 | ||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | ||||||||||||
| cash flow from financing | 0 | 0 | 1 | ||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
national pharmaceutical association limited Credit Report and Business Information
National Pharmaceutical Association Limited Competitor Analysis
Perform a competitor analysis for national pharmaceutical association limited by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in AL1 area or any other competitors across 12 key performance metrics.
national pharmaceutical association limited Ownership
NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED group structure
National Pharmaceutical Association Limited has 1 subsidiary company.
Ultimate parent company
1 parent
NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED
04141489
1 subsidiary
national pharmaceutical association limited directors
National Pharmaceutical Association Limited currently has 3 directors. The longest serving directors include Mr Michael Guerin (Apr 2014) and Mr Nick Kaye (Oct 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Michael Guerin | 61 years | Apr 2014 | - | Director | |
| Mr Nick Kaye | 49 years | Oct 2022 | - | Director | |
| Mr Andrew Lane | England | 65 years | Oct 2022 | - | Director |
P&L
December 2023turnover
4.4
0%
operating profit
0
0%
gross margin
40.7%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1
0%
total assets
1
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
national pharmaceutical association limited company details
company number
04141489
Type
Private limited with Share Capital
industry
94110 - Activities of business and employers membership organisations
incorporation date
January 2001
age
23
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
national pharmacy association limited (July 2005)
askyourpharmacist.co.uk ltd (May 2005)
accountant
-
auditor
-
address
mallinson house, 38-42 st peters street, st albans, herts, AL1 3NP
Bank
-
Legal Advisor
-
national pharmaceutical association limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to national pharmaceutical association limited.
national pharmaceutical association limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED. This can take several minutes, an email will notify you when this has completed.
national pharmaceutical association limited Companies House Filings - See Documents
| date | description | view/download |
|---|
